Stabilizing effects of calcium alginate microspheres on mycobacterium bovis BCG intended for oral vaccination

References

• Aldwell FE, Baird MA, Fitzpatrick CE, Mclellan AD, Cross ML, Lambeth MR, Buchan GS. Oral vaccination of mice with lipid-encapsulated mycobacterium bovis BCG: Anatomical sites of bacterial replication and immune activity. Immunology and Cell Biology 2005; 83: 549–553
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Cross ML, Fitzpatrick CE, Lambeth MR, Lisle GW, Buddle BM. Oral delivery of lipid-encapsulated mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Vaccine 2006; 24: 2071–2078
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Keen DL, Parlan NA, Skinner MA, Lisle GW, Buddle BM. Oral vaccination with mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brush tail possums. Vaccine 2003a; 22: 70–76
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Tukker IG, Lisle GW, Buddle BM. Oral delivery of mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infection and Immunity 2003b; 71: 101–108
   PubMed Web of Science ®Google Scholar
• Bhopatkar D, Anal AK, Stevens WF. Ionotropic alginate beads for controlled intestinal delivery: Effect of chitosan and barium counter-ions on entrapment and release. Journal of Microencapsulation 2005; 22: 91–100
   PubMed Web of Science ®Google Scholar
• Boon C, Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. Journal of Bacteriology 2002; 184: 6760–6767
   PubMed Web of Science ®Google Scholar
• Bowersock TL, Hogenesch H, Suckow M, Guimond P, Martin S, Borie D, Torregrosa S, Park H, Park K. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 1999; 17: 1804–1811
   PubMed Web of Science ®Google Scholar
• Bowersock TL, Park K, Poter RE. Alginate-based vaccine compositions. United States Patent No. 5674495, 1997
   Google Scholar
• Chattaraj SC, Rathinavelu A, Das SK. Biodegradable microparticles of influenza viral vaccine: Comparison of the effects of routes of administration on the in vivo immune response in mice. Journal of Controlled Release 1999; 58: 223–232
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharmaceutical Research 1996; 13: 1838–1845
   PubMed Web of Science ®Google Scholar
• Esquisabel A, Hernandez RM, Igartua M, Gascon AR, Calvo B, Pedraz JL. Effect of lecithins on BCG-alginate–PLL microcapsule particle size and stability upon storage. Journal of Microencapsulation 2000; 17: 363–372
   PubMed Web of Science ®Google Scholar
• Fine PEM, Carneiro IAM, Milstien JB, Clements CJ. Issues relating to the use of BCG in immunization programmes. World Health Organization, Department of Vaccines and Biologicals, Geneva 1999
   Google Scholar
• Gheorghiu M, Lagranderie M, Balazuc AM. Stabilisation of BCG vaccines. New approaches to stabilisation of vaccine potency. Developments in Biological Standards 1996; 87: 251–261
   PubMedGoogle Scholar
• Guo JF, Jourdian GW, Maccallum DK. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connective Tissue Research 1989; 19: 277–97
   PubMed Web of Science ®Google Scholar
• Kierstan M, Bucke C. The immobilization of microbial cells, subcellular organelles, and enzymes in calcium alginate gels. Biotechnology and Bioengineering 1977; 19: 387–397
   PubMed Web of Science ®Google Scholar
• Kim B, Bowersock T, Griebel P, Kidan A, Babuik LA, Sanchez M, Attah-poku S, Kaushik RS, Mutwiri GK. Mucosal immune response following oral immunization with rotavirus antigens encapsulated in alginate microspheres. Journal of Controlled Release 2002; 85: 191–202
   PubMed Web of Science ®Google Scholar
• Kremer L, Dupre L, Riveau G, Capron A, Locht C. Systemic and mucosal immune responses after intranasal administration of recombinant mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from schistosoma haematobium. Infection and Immunity 1998; 66: 5669–5676
   PubMed Web of Science ®Google Scholar
• Kumar TM, Paul W, Sharma CP, Kuriachan MA. Bioadhesive, pH responsive micromatrix for oral delivery of insulin. Trends in Biomaterials and Artificial Organs 2005; 18: 198–202
   Google Scholar
• Kwok KK, Groves MJ, Burgess DJ. Production of 5–15 µm diameter alginate-polylysine microcapsules by an air-atomization technique. Pharmaceutical Research 1991; 8: 341–344
   PubMed Web of Science ®Google Scholar
• Lagranderie M, Chavarot P, Balazuc AM, Marchal G. Immunogenicity and protective capacity of mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine 2000; 18: 1186–1195
   PubMed Web of Science ®Google Scholar
• Lee S, Ang WS, Elimelech M. Fouling of reverse osmosis membranes by hydrophilic organic matter: Implication for water reuse. Desalination 2006; 187: 313–321
   Web of Science ®Google Scholar
• Lee S, Elimelech M. Relating organic fouling of reverse osmosis membrane to intermolecular adhesion forces. Environmental Science & Technology 2006; 40: 980–987
   PubMed Web of Science ®Google Scholar
• Lemoine D, Wauters F, Bouchend'homme S, Preat V. Preparation and characterization of alginate microspheres containing a model antigen. International Journal of Pharmaceutics 1998; 176: 9–19
   Web of Science ®Google Scholar
• Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T. Oxygen depletion-induced dormancy in mycobacterium bovis BCG. Journal of Bacteriology 1999; 181: 2252–2256
   PubMedGoogle Scholar
• Lin YH, Liang HF, Chung CK, Chen MC, Sung HW. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 2005; 26: 2105–2113
   PubMed Web of Science ®Google Scholar
• Mortatti RC, Maia LC, Fonseca LS. Absorption of Mycobacterium bovis BCG administered by the oral route. Vaccine 1987; 5: 109–114
   PubMed Web of Science ®Google Scholar
• Ostberg T, Lund EM, Graggner C. Calcium alginate matrices for oral multiple unit administration: i.v release characteristics in different media. International Journal of Pharmaceutics 1994; 112: 241–248
   Web of Science ®Google Scholar
• Plorde JJ. Mycobacteria. Sherris medical microbiology. 4th ed, KJ Ryan, CG Ray. McGraw-Hill, New York 2004; 439–456
   Google Scholar
• Qurrat-ul-ain, Sharma S, Lhuller GK, Garag SK. Alginate-based oral drug delivery system for tuberculosis: Pharmacokinetics and therapeutic effects. Journal of Antimicrobial Chemotherapy 2003; 51: 931–938
   PubMedGoogle Scholar
• Sankalia MG, Mashru RC, Sankalia JM, Sutaria VB. Papain entrapment in alginate beads for stability improvement and site-specific delivery: Physicochemical characterization and factorial optimization using neural network modeling. AAPS Pharmaceutical Sciences & Technology 2005; 6: E209–E222
   PubMed Web of Science ®Google Scholar
• Silva CM, Ribeiro AJ, Figueiredo M, Ferreira D, Veiga F. Microencapsulation of hemoglobin in chitosan-coated alginate microspheres prepared by emulsification/internal gelation. The AAPS Journal 2006; 7: E903–E913
   Web of Science ®Google Scholar
• Simpson NE, Grants SC, Blackband SJ, Constantinidis J. NMR properties of alginate microbeads. Biomaterials 2003; 24: 4941–4948
   PubMedGoogle Scholar
• Smidsrod O, Skjak-Braek G. Alginate as immobilization matrix for cells. Trends in Biotechnology 1990; 8: 71–78
   PubMed Web of Science ®Google Scholar
• Smith KC, Plothin A, Stark JR, Orenstein A. Bacillus Calmette-Guerin vaccine. Vaccine. 3rd ed, Plotkin, Orenstein. WB Saunders Company, Philadelphia 1999; 111–139
   Google Scholar
• Sone T, Nagamori E, Ikeuchi T, Mizukami A, Takakura Y, Kajiyama S, Fukusaki E, Harashima S, Kobayashi A, Fukui K. A novel gene delivery system in plants with calcium alginate micro-beads. Journal of Bioscience and Bioengineering 2002; 94: 87–91
   PubMed Web of Science ®Google Scholar
• Suckow MA, Bowersock TL, Park H, Park K. Oral immunization of rabbits against pasteurella multocida with an alginate microsphere delivery system. Journal of Biomaterials Science, Polymer Edition 1996; 8: 131–139
   PubMedGoogle Scholar
• Takka S, Acarturk F. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency. Journal of Microencapsulation 1999; 16: 275–290
   PubMed Web of Science ®Google Scholar
• Wan J, Gordon JB, Muirhead K, Hickey MW, Coventry MJ. Incorporation of nisin in micro-particles of calcium alginate. Letters in Applied Microbiology 1997; 24: 153–158
   PubMed Web of Science ®Google Scholar
• Yeh P, Ellens H, Smith PL. Physiological consideration in the design of particulate dosage forms for oral vaccine delivery. Advanced Drug Delivery Reviews 1998; 34: 123–133
   PubMed Web of Science ®Google Scholar